Cargando…
The LLP risk model: an individual risk prediction model for lung cancer
Using a model-based approach, we estimated the probability that an individual, with a specified combination of risk factors, would develop lung cancer within a 5-year period. Data from 579 lung cancer cases and 1157 age- and sex-matched population-based controls were available for this analysis. Sig...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361453/ https://www.ncbi.nlm.nih.gov/pubmed/18087271 http://dx.doi.org/10.1038/sj.bjc.6604158 |
_version_ | 1782153214625316864 |
---|---|
author | Cassidy, A Myles, J P van Tongeren, M Page, R D Liloglou, T Duffy, S W Field, J K |
author_facet | Cassidy, A Myles, J P van Tongeren, M Page, R D Liloglou, T Duffy, S W Field, J K |
author_sort | Cassidy, A |
collection | PubMed |
description | Using a model-based approach, we estimated the probability that an individual, with a specified combination of risk factors, would develop lung cancer within a 5-year period. Data from 579 lung cancer cases and 1157 age- and sex-matched population-based controls were available for this analysis. Significant risk factors were fitted into multivariate conditional logistic regression models. The final multivariate model was combined with age-standardised lung cancer incidence data to calculate absolute risk estimates. Combinations of lifestyle risk factors were modelled to create risk profiles. For example, a 77-year-old male non-smoker, with a family history of lung cancer (early onset) and occupational exposure to asbestos has an absolute risk of 3.17% (95% CI, 1.67–5.95). Choosing a 2.5% cutoff to trigger increased surveillance, gave a sensitivity of 0.62 and specificity of 0.70, while a 6.0% cutoff gave a sensitivity of 0.34 and specificity of 0.90. A 10-fold cross validation produced an AUC statistic of 0.70, indicating good discrimination. If independent validation studies confirm these results, the LLP risk models’ application as the first stage in an early detection strategy is a logical evolution in patient care. |
format | Text |
id | pubmed-2361453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23614532009-09-10 The LLP risk model: an individual risk prediction model for lung cancer Cassidy, A Myles, J P van Tongeren, M Page, R D Liloglou, T Duffy, S W Field, J K Br J Cancer Clinical Study Using a model-based approach, we estimated the probability that an individual, with a specified combination of risk factors, would develop lung cancer within a 5-year period. Data from 579 lung cancer cases and 1157 age- and sex-matched population-based controls were available for this analysis. Significant risk factors were fitted into multivariate conditional logistic regression models. The final multivariate model was combined with age-standardised lung cancer incidence data to calculate absolute risk estimates. Combinations of lifestyle risk factors were modelled to create risk profiles. For example, a 77-year-old male non-smoker, with a family history of lung cancer (early onset) and occupational exposure to asbestos has an absolute risk of 3.17% (95% CI, 1.67–5.95). Choosing a 2.5% cutoff to trigger increased surveillance, gave a sensitivity of 0.62 and specificity of 0.70, while a 6.0% cutoff gave a sensitivity of 0.34 and specificity of 0.90. A 10-fold cross validation produced an AUC statistic of 0.70, indicating good discrimination. If independent validation studies confirm these results, the LLP risk models’ application as the first stage in an early detection strategy is a logical evolution in patient care. Nature Publishing Group 2008-01-29 2007-12-18 /pmc/articles/PMC2361453/ /pubmed/18087271 http://dx.doi.org/10.1038/sj.bjc.6604158 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study Cassidy, A Myles, J P van Tongeren, M Page, R D Liloglou, T Duffy, S W Field, J K The LLP risk model: an individual risk prediction model for lung cancer |
title | The LLP risk model: an individual risk prediction model for lung cancer |
title_full | The LLP risk model: an individual risk prediction model for lung cancer |
title_fullStr | The LLP risk model: an individual risk prediction model for lung cancer |
title_full_unstemmed | The LLP risk model: an individual risk prediction model for lung cancer |
title_short | The LLP risk model: an individual risk prediction model for lung cancer |
title_sort | llp risk model: an individual risk prediction model for lung cancer |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361453/ https://www.ncbi.nlm.nih.gov/pubmed/18087271 http://dx.doi.org/10.1038/sj.bjc.6604158 |
work_keys_str_mv | AT cassidya thellpriskmodelanindividualriskpredictionmodelforlungcancer AT mylesjp thellpriskmodelanindividualriskpredictionmodelforlungcancer AT vantongerenm thellpriskmodelanindividualriskpredictionmodelforlungcancer AT pagerd thellpriskmodelanindividualriskpredictionmodelforlungcancer AT liloglout thellpriskmodelanindividualriskpredictionmodelforlungcancer AT duffysw thellpriskmodelanindividualriskpredictionmodelforlungcancer AT fieldjk thellpriskmodelanindividualriskpredictionmodelforlungcancer AT cassidya llpriskmodelanindividualriskpredictionmodelforlungcancer AT mylesjp llpriskmodelanindividualriskpredictionmodelforlungcancer AT vantongerenm llpriskmodelanindividualriskpredictionmodelforlungcancer AT pagerd llpriskmodelanindividualriskpredictionmodelforlungcancer AT liloglout llpriskmodelanindividualriskpredictionmodelforlungcancer AT duffysw llpriskmodelanindividualriskpredictionmodelforlungcancer AT fieldjk llpriskmodelanindividualriskpredictionmodelforlungcancer |